Bela Denes joins Clarus as CMO
This article was originally published in Scrip
Executive Summary
Clarus Therapeutics, a privately-held Illinois-based biopharma with an oral T replacement product, CLR-610, in Phase III, has appointed Dr Bela Denes chief medical officer. Dr Denes was most recently senior medical director at Abbott Laboratories, and has over 35 years of urology experience.